Kwon Boseong, Lee Ki Baek, Yoon Jong-Tae, Choi Joon Ho, Lee Deok Hee, Song Yunsun
Department of Radiology, Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Biomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea.
Neurointervention. 2022 Nov;17(3):143-151. doi: 10.5469/neuroint.2022.00248. Epub 2022 Jul 28.
The purpose of this study was to evaluate the safety and effectiveness of a new angiographic system (Catheter 3.0 system) using a 5 French (Fr), large-bore angiography catheter, a 0.032-inch stiff guidewire, and a continuous flushing system in diagnostic cerebral angiography.
This retrospective study included 30 consecutive patients who underwent transfemoral cerebral angiography using the Catheter 3.0 system from October 2019 to March 2020. As the control group, we included 30 consecutive patients examined before the Catheter 3.0 system was introduced. Procedural outcomes, including technical success, procedure time, dose metrics, procedure-related complications, and image quality were reviewed and analyzed.
All transfemoral cerebral angiographies were performed for a diagnosis of unruptured intracranial aneurysms. The Catheter 3.0 system showed a significantly shorter fluoroscopy time (6.2 vs. 9.7 minutes, P=0.008) and lower fluoroscopy dose (387.2 vs. 614.4, P=0.002) compared with the conventional 4-Fr catheter system. The Catheter 3.0 system also showed better results in terms of procedural time (21.0 vs. 22.5 minutes, P=0.072) and technical success rate (98.1% vs. 94.0%, P=0.078), although a statistical significance was not reached. The complication rate and qualitative assessment of the digital subtraction angiography (DSA) image quality were similar between the two groups.
The Catheter 3.0 system using a 5 Fr catheter with a large inner diameter was convenient, effective, and safe compared with the conventional system in diagnostic cerebrovascular angiography.
本研究旨在评估一种新型血管造影系统(导管3.0系统)在诊断性脑血管造影中使用5法国(Fr)大口径血管造影导管、0.032英寸硬导丝和连续冲洗系统的安全性和有效性。
这项回顾性研究纳入了2019年10月至2020年3月期间连续30例使用导管3.0系统进行经股动脉脑血管造影的患者。作为对照组,我们纳入了在导管3.0系统引入之前连续检查的30例患者。对包括技术成功率、操作时间、剂量指标、与操作相关的并发症和图像质量在内的操作结果进行了回顾和分析。
所有经股动脉脑血管造影均用于诊断未破裂颅内动脉瘤。与传统的4 Fr导管系统相比,导管3.0系统的透视时间显著缩短(6.2分钟对9.7分钟,P = 0.008),透视剂量更低(387.2对614.4,P = 0.002)。导管3.0系统在操作时间(21.0分钟对22.5分钟,P = 0.072)和技术成功率(98.1%对94.0%,P = 0.078)方面也显示出更好的结果,尽管未达到统计学意义。两组之间数字减影血管造影(DSA)图像质量的并发症发生率和定性评估相似。
与传统系统相比,使用内径较大的5 Fr导管的导管3.0系统在诊断性脑血管造影中方便、有效且安全。